XUPREMAB

Serial Number 97838863
Registration 7600728
700

Registration Progress

Application Filed
Mar 14, 2023
Under Examination
Mar 19, 2024
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered
Dec 10, 2024

Trademark Image

XUPREMAB

Basic Information

Serial Number
97838863
Registration Number
7600728
Filing Date
March 14, 2023
Registration Date
December 10, 2024
Published for Opposition
January 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 10, 2024
Registration
Registered
Classes
042

Rights Holder

Shenzhen Jingtai Technology Co., Ltd.

99
Address
Floor 3, 289 Digitland, No.2 Hongliu Rd.
Fubao Community,Fubao Str., Futian Dist.
Shenzhen, Guangdong 518000
CN

Ownership History

Shenzhen Jingtai Technology Co., Ltd.

Original Applicant
99
Shenzhen, Guangdong CN

Shenzhen Jingtai Technology Co., Ltd.

Owner at Publication
99
Shenzhen, Guangdong CN

Shenzhen Jingtai Technology Co., Ltd.

Original Registrant
99
Shenzhen, Guangdong CN

Legal Representation

Attorney
Paulo A. de Almeida

USPTO Deadlines

Next Deadline
1968 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-10)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description Documents
Dec 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 18, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 18, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 8, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 8, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 5, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 5, 2024 IUAF S USE AMENDMENT FILED Loading...
Mar 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 14, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 11, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 17, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Biochemical research and development; Biomedical research services; Cloud computing featuring software for use antibody development, medical research and drug discovery; Cloud storage services for electronic data; Conducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, antibody iptimization and macromolecule drug discovery; Development of pharmaceutical preparations and medicines; DNA sequencing technology research; Drug discovery services; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical product evaluation; Product quality testing; Rental of laboratory apparatus and instruments; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Research in the field of chemistry; Research in the field of manufacturing machinery; Research on the subject of pharmaceuticals
First Use Anywhere: May 15, 2023
First Use in Commerce: May 15, 2023

Classification

International Classes
042